Jinfiniti Precision Medicine

Jinfiniti Precision Medicine is an Augusta, Georgia company founded in 2018 by Dr. Jin-Xiong She, a Georgia Research Alliance Eminent Scholar, who serves as CEO and Chief Scientific Officer. Operating a high-complexity CLIA laboratory, Jinfiniti developed what it describes as the first clinical-grade intracellular NAD+ test in 2019 and says it processes the large majority of NAD+ tests performed worldwide. Beyond NAD+, it offers assays for oxidative stress and senescent-cell burden, and it sells targeted supplements such as NAD+ boosters intended to correct deficiencies identified through testing, pairing diagnostics with intervention.